The application of autologous platelet rich fibrin reduces allogeneic blood transfusions and improves wound healing in total hip arthroplasty

Completed

• Conditions: coxarthrosis; 10019815; 10023213; 10005944

• Registration Number: NL-OMON29827
• Lead Sponsor: Catharina-ziekenhuis

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Last Update Posted: 24 June 2024

Recruitment & Eligibility

• Status: Completed
• Sex: Not specified
• Target Recruitment: 152

Inclusion Criteria

patients with primary ostheoarthritis who need total hip arthroplasty

Exclusion Criteria

coagulation diseases, use of anticoagulant drugs, renal problems or failure, liver disease, and malignant disease

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
<p>Transfusion of homologous blood products<br /><br>Surgical wound healing<br /><br><br /><br><br /><br><br /><br><br /><br></p><br>

Secondary Outcome Measures

Name	Time	Method
<p>Patient characteristics<br /><br>Surgical wound leakage<br /><br>Surgical wound infection<br /><br>Pain medication<br /><br>Risk factors for wound healing disturbances<br /><br>Red Blood Cell Mass<br /><br>Surgical information<br /><br>PRF application-data<br /><br>Blood management-data</p><br>